← Back to Search

Behavioral Intervention

LARKSPUR; Online Positive Emotions Skills for Individuals with Chronic Musculoskeletal Pain for Chronic Pain (LARKSPUR Trial)

N/A

Waitlist Available

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up administered at 8 weeks post baseline

Awards & highlights

LARKSPUR Trial Summary

This trial is testing a tailored online intervention to help people with chronic pain cope, in the hopes of decreasing depression and distress.

Eligible Conditions

Chronic Pain
Musculoskeletal Pain

LARKSPUR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ administered at baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~administered at baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and administered at baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Retention to the LARKSPUR Study from baseline to 12 weeks post baseline

Retention to the LARKSPUR Study from baseline to 8 weeks post baseline

Secondary outcome measures

Anxiety at 12 weeks post baseline using the PROMIS measure

Anxiety at 8 weeks post baseline using the PROMIS measure

Anxiety at baseline using the PROMIS measure

+42 more

Other outcome measures

Results of physical examinations in the patient's Electronic Health Record at 12 weeks post baseline

Use of non-prescription medication in the patient's Electronic Health Record at 12 weeks post baseline

Use of prescription medication in the patient's Electronic Health Record at 12 weeks post baseline

LARKSPUR Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Participants will receive the online LARKSPUR intervention which lasts about 5-6 weeks, receiving the positive emotions skills through the website, and logging on to the website for about 5-10 minutes each day for that period. Assessments will be taken at baseline, post-intervention (8 weeks after the baseline), and 12 weeks after baseline (1 month post intervention).

Group II: Emotion Reporting ControlActive Control1 Intervention

Participants will report their emotions for 5-6 weeks by logging on to the website for about 5 minutes each day. Assessments will be taken at baseline, 8 weeks after baseline, and 12 weeks after baseline. After 12 weeks, participants will receive access to the LARKSPUR intervention online.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

LARKSPUR; Online Positive Emotions Skills for Individuals with Chronic Musculoskeletal Pain

2018

N/A

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

BraveNetOTHER

1 Previous Clinical Trials

5,069 Total Patients Enrolled

Northwestern UniversityLead Sponsor

1,591 Previous Clinical Trials

917,572 Total Patients Enrolled

12 Trials studying Chronic Pain

3,779 Patients Enrolled for Chronic Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is access to this research trial currently available for participants?

"As indicated on clinicaltrials.gov, this medical trial is no longer actively enrolling participants as the most recent update was made on March 3rd 2022. Although this specific study has ceased recruitment, 443 other clinical studies are still open for enrolment."

Answered by AI

What is the projected outcome of this trial?

"The principal end-point of this trial, measured from the initial baseline to 8 weeks after said point, focuses on the retention rate for patients enrolled in LARKSPUR. Secondary goals include a Pain Intensity assessment at 8 weeks post baseline using the PROMIS Scale v1.0 - Pain Intensity 3a; examining patient adherence with MOS measures during enrolment, and self reported medication use through an affirmative response query with 13 optional medications listed alongside two subsequent questions regarding their dosage strength and frequency of intake."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Lessons in Affect Regulation to Keep Stress and Pain UndeR Control (LARKSPUR R34)

Judith Moskowitz 2018. "Lessons in Affect Regulation to Keep Stress and Pain UndeR Control (LARKSPUR R34)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03699553.